SEARCH RESULTS for assignee:"novartis ag"

Showing 1 to 20 of 562 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15672568: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

(A1) 20180028532: AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14861797: MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

(A1) 20160051523: MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15454187: ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS

(A1) 20170174640: ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS

(B2) 9: ISOXAZOLINE HYDROXAMIC ACID DERIVATIVES AS LpxC INHIBITORS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15975934: OPHTHALMIC SURGICAL SYSTEM WITH INFUSION FLUID AND SUBSTANCE DELIVERY THROUGH AN INFUSION CANNULA

(A1) 20180338861: OPHTHALMIC SURGICAL SYSTEM WITH INFUSION FLUID AND SUBSTANCE DELIVERY THROUGH AN INFUSION CANNULA

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15987131: ILLUMINATED INFUSION CANNULA

(A1) 20180338860: ILLUMINATED INFUSION CANNULA

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15973909: OPHTHALMIC ENDOILLUMINATOR

(A1) 20180338859: OPHTHALMIC ENDOILLUMINATOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15974818: ILLUMINATED INFUSION CANNULA

(A1) 20180338776: ILLUMINATED INFUSION CANNULA

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15105074: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

(A1) 20160311907: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15105074: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

(A1) 20160311907: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(A1) 20160311907: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

(X0) 15105074: REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 14897439: MODIFIED RELEASE FORMULATION

(A1) 20160128979: MODIFIED RELEASE FORMULATION

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16038860: CELL BAG ROTATOR

(A1) 20180326377: CELL BAG ROTATOR

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15985060: NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

(A1) 20180326079: NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16042062: SYSTEMS AND PROCESSES FOR INSERTING AN INTRAOCULAR LENS

(A1) 20180325659: SYSTEMS AND PROCESSES FOR INSERTING AN INTRAOCULAR LENS

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 16033764: Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

(A1) 20180325883: Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

Assignee(s)